πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7504246

Hyaluronan synthase gene and uses thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7504231

Method of alleviating chronic pain via peripheral inhibition of neurotransmitter synthesis

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7494775

Compositions, kits, and methods for identification, assessment, prevention and therapy of

UT Board of Regents Β· Granted Tue Feb 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479550

Amyloid Ξ² gene vaccines

The Board of Regents of the University of Texas System Β· Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7473772

Chimeric GB virus B (GBV-B)

The Board of Regents of the University of Texas System Β· Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7470776

Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468379

Inhibition of osteolytic lesions by SRC kinase inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7465784

Antimicrobial peptides and methods of identifying the same

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7462609

Narcistatin prodrugs

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7455833

Methods and compositions for treating viral infections using antibodies and immunoconjugat

The Board of Regents of the University of Texas System Β· Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452971

Compositions and methods for modifying toxic effects of proteinaceous compounds

The Board of Regents of the University of Texas System Β· Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452964

Compositions and methods of use of targeting peptides against placenta and adipose tissues

The Board of Regents of the University of Texas System Β· Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7446124

Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

Arizona Board of Regents, Acting on Behalf of the University of Arizona Β· Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7446182

Recombinant antibodies for the detection and neutralization of anthrax toxin

The Board of Regents of the University of Texas System Β· Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7438914

Composition and method for enhancing immune response

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7439265

Irciniastatins a and b

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7435755

CDDO-compounds and combination therapies thereof

The Board of Regents of the University of Texas System Β· Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7431929

Use of vaccinia virus deleted for the E3L gene as a vaccine vector

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7429616

Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as ant

The Board of Regents of the University of Texas System Β· Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7423015

Antihelminthic drugs as a treatment for hyperproliferative diseases

The Board of Regents of the University of Texas System Β· Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7422738

Combined cancer treatment methods using antibodies to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7420030

Aminopeptidase A (APA) targeting peptides for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7420100

Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

The Board of Regents of the University of Texas System Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7417037

Compositions and methods of treatment for inflammatory diseases

The Board of Regents of the University of Oklahoma Β· Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted